This study aimed to prospectively evaluate and correlate the results of histomorphometric analysis of bone biopsies after kidney transplantation, observed and discussed in our first paper, with emerging serum biomarkers of the CKD-MBD spectrum: Sclerostin, Dkk-1, sRANKL and OPG. This evidence concerns the gene SOST and chronic kidney disease.